© 2026 Sinochem Nanjing Corporation,
All Right Reserved
Benproperine phosphate has a story that traces back to the mid-20th century, when medical research in Europe and Japan searched for new ways to relieve cough without relying on narcotics. Developers focused on arylalkylamines, a chemical class showing promise as alternatives to codeine. Benproperine found favor, especially in Japan and other Asian markets, because it reduced cough reflex through action on the medullary center without sedation or dependence, two problems plaguing earlier options. Over the years, regulatory bodies across Asia and Europe evaluated its safety, leading to its approval as a prescription and, in certain countries, as an over-the-counter medication. In the clinic and pharmacy, benproperine built a reputation for reliability, minimal drug interactions, and a safety profile superior to most traditional expectorants.
Patients and doctors recognize benproperine phosphate mainly as a cough suppressant. Tablets and syrups dominate the market, with doses tailored for adults and children. It stands apart from narcotic antitussives, offering relief from persistent nonproductive coughs linked to throat irritation, bronchitis, or post-infectious conditions. It performs best where coughs disrupt sleep or everyday life but do not require powerful opioid-based treatments. Pharmacies stock it under names including Tussidril, Bepotine, and Prospan, with combinations containing antihistamines or expectorants appearing across Asia and Eastern Europe.
At room temperature, benproperine phosphate appears as a white crystalline powder with a faint chemical odor. Its molecular formula is C21H29NO4·H3PO4, reflecting its structure as a phosphate salt of a piperidine derivative. Laboratory analysis shows a melting point around 87–92°C. It dissolves moderately in water and even better in alcohol. Spectral fingerprinting using IR and NMR helps confirm identity in manufacturing and quality control. The compound remains stable in dry, cool storage away from direct sunlight, sidestepping problems with decomposition that plague some older antitussives.
Pharmaceutical manufacturers adhere to strict purity standards, with active benproperine phosphate consisting of at least 98% assay values by HPLC. Regulatory monographs demand thorough screening for related impurities, typically capped below 0.2%, and heavy metals far below international thresholds. Packaging must discourage moisture ingress, as clumping or hydrolysis could lead to inconsistent dosing. Labels list not just benproperine content but all excipients, storage instructions, manufacturer batch location, and an expiry date calculated from validated stability studies. In nations like Japan and Germany, dosing guidelines and potential side effects go front and center, putting responsibility for informed use onto both the pharmacist and consumer.
Industrial production relies on reactions between benzhydryl chloride and 1-(2-piperidyl)propanol, catalyzed in an appropriate solvent. The crude benproperine base gets purified, often through recrystallization or column chromatography, until reaching pharmaceutical grade. Once isolation finishes, the base reacts with phosphoric acid, yielding the phosphate salt with a predictable and repeatable stoichiometry. Cleaning steps include washing with organic solvents and drying under vacuum, both proven over decades of scaled-up synthesis. Profiling the final product, chemists test both for yield and purity before pressing into tablets or compounding into syrup.
Benproperine’s structure offers certain flexibility for chemists but leaves little need or room for routine modification. Substitutions at the piperidine ring, aromatic nucleus, or propanol chain do appear in literature, but modifications rarely outperform the original’s cough-suppressing action without raising toxicity or losing oral bioavailability. Derivatives might tweak duration of action or absorption profile but only rarely reach the market. Its phosphate group enhances water solubility, justifying its use in syrups for children and rapid-onset formulations.
In pharmacy and scientific literature, benproperine phosphate turns up under names like 1-[2-[(2-benzhydryloxy)ethyl]piperidino]propan-1-ol phosphate, Bepotine, or Tussidril. Japanese formularies recognize it as ベンプロペリンリン酸塩. Naming conventions change across borders, confusing patients who travel or move. Yet, the compound’s unique structure and antitussive reputation always bridge the communication gap.
Quality manufacturing starts and ends with rigorous safety routines. Technicians operate in well-ventilated spaces with proper gloves, face masks, and, for powder handling, respirators. Material transfer avoids airborne dust, thanks to localized extraction units and humidity control. Regulatory checks ensure compliance with ICH and national guidelines. Facilities must document every step, test every lot for purity, microbial content, and uniformity, and retain backup samples for years. Emergencies, such as accidental skin contact or inhalation, trigger immediate rinsing and medical review, but statistics rarely turn up incidents when protocols get followed.
Doctors in respiratory clinics, pediatric wards, and outpatient settings often turn to benproperine for patients struggling with irritating, dry coughs. Unlike opioids, it brings relief without constipation, dizziness, or addiction. Parents value syrup forms suitable for children, since it causes fewer sedative effects than rival drugs, letting kids rest at night without turning groggy the next morning. Pulmonologists sometimes recommend it post-infection to quiet coughs that linger after the actual illness abates. In pharmacies, over-the-counter combinations help families deal with seasonal coughs, especially where codeine regulations bite hardest.
Benproperine rarely makes global headlines, yet researchers haven’t forgotten it. Scientists measure its interaction with modern antibiotics, antihistamines, and asthma medications, confirming its compatibility in most cases. Research explores its neuropharmacology, mapping its weak binding to opioid receptors and stronger effect through peripheral mechanisms. Newer studies question if modified-release forms might help specific patient groups, such as the elderly, who risk drowsiness with classic drugs. Chemists keep looking for analogs hoping to extend its use or further reduce rare side effects, but changing regulation and tougher clinical trial demands slow progress. Recent publications study genetic polymorphisms affecting benproperine metabolism, aiming for personalized dosing.
Animal models and clinical cohorts both report low acute toxicity from benproperine. At therapeutic doses, side effects often confine themselves to mild nausea, headache, or restlessness. Overdoses, either accidental or intentional, very rarely lead to serious complications such as ataxia or confusion, and they seldom require hospital-level care. Long-term studies highlight minimal risk for organ damage or carcinogenicity, contrasting sharply with much older antitussives that left toxic byproducts in the body. Teratogenicity screening among animals shows no increase in birth defects, but prudence keeps it off the table for use during pregnancy unless symptoms prove debilitating. Regulatory agencies keep collecting post-market data, but adverse effects continue to show up infrequently.
Benproperine phosphate faces a changing medical landscape. New cough therapies jostle for space, but benproperine has a place by virtue of its familiar risk profile and global acceptance. Generics keep prices low and access broad, a welcome counterbalance to the explosion of high-cost branded drugs. Future research may adjust dosing in special groups, refine controlled-release formulations, or pair it with digital health apps that help track cough events at home. Pharmacogenomic advances could tailor doses by genetic type, further squeezing out rare side effects. Regulatory tightening on opioids and certain antihistamines could push wider adoption, especially as health systems look for effective but low-risk options for both adults and children fighting the common cold and seasonal bronchitis.
Benproperine phosphate shows up on pharmacy shelves every cold season, tucked in behind the counter, ready for a doctor’s signature. At its core, this medicine aims to quiet a nagging, dry cough. Not every cough needs to get suppressed, but in some cases, those hacking fits keep people awake, cause chest pain, or even disrupt work and social life. I remember one winter, I fought a persistent tickle—nothing soothed it. A doctor suggested a cough suppressant, and I got a script for benproperine phosphate. It got me sleeping again after weeks of restless nights.
Doctors choose benproperine phosphate for its ability to cut down cough reflexes without making people sleepy. Unlike codeine, which sits in many older cough formulas and comes with a cloud of side effects and risks, benproperine doesn’t carry that same baggage. It works by settling down the urge to cough right at its source in the brain, not by blunting brain activity overall. Studies back up its safety—even children and older adults tolerate it pretty well, provided the dosages stay right.
A relentless cough brings more than annoyance. It interrupts healing, strains muscles, and raises the risk of hurting ribs or pulling muscles, especially in older folks or anyone with other health problems. Once, a friend with chronic bronchitis told me just a single day with his cough under control let him work a full shift and sleep through the night, a rare gift in his world.
Benproperine phosphate finds its place in hospitals, too. For certain respiratory illnesses, especially those where a dry cough hinders recovery or increases pain, the ability to manage this symptom safely means a lot. There’s no narcotic risk, so doctors and patients don’t have to weigh cough relief against the dangers of addiction.
Of course, no medicine comes without possible trouble. Nausea, a bit of dizziness, or mild stomach discomfort sometimes crop up—but these issues usually fade fast. I’ve found that patients want to know one thing: will it interact with their other prescriptions? Doctors check for drug conflicts before handing out the script, especially for folks with serious medical conditions.
Some people think every cough should get shut down. That's not always true. Coughing plays a role, clearing germs and mucus out of the lungs. Benproperine phosphate isn’t for productive coughs, where phlegm needs to get out. Knowing the difference matters—a qualified healthcare provider guides that call.
Access to effective, well-tested cough medicine matters in family clinics and specialist offices alike. In places where over-the-counter codeine got restricted, non-opioid options stepped up to keep people out of misery. Benproperine phosphate fills that gap, offering reliable relief without fuss. Parents bringing in kids struggling to sleep, or adults kept awake by that stubborn tickle, have a useful option—one with decades of clinical use behind it.
It comes back to balance. Medicines like benproperine phosphate support healing, improve life in small but critical ways, and let folks get back to their lives without the drama that old-fashioned cough syrups sometimes brought along. That practical support matches what people need most during cold and flu season.
Benproperine phosphate turns up in cough medicines across Asia. It’s been in medicine cabinets for decades, earning trust from families and doctors. Selling points promise fast cough relief. Many folks barely glance at the detailed fine print bundled with the box. I once did the same, grabbing what the pharmacist suggested, as a hacking cough wore me down. It worked, but after a few doses, my head felt fuzzy and my stomach churned. That nap I took in the middle of the day? Not my usual style.
Most people, thinking they’re just in for a smoother cough, don’t expect much besides maybe some drowsiness. Skimming through medical studies, it becomes obvious that side effects extend beyond a little sleepiness. Common reactions like nausea, vomiting, and headaches come up in medical reports. Some folks run into dizziness, or a dry mouth that feels like they've chewed on cotton. For the unlucky minority, things get a bit more complex. Allergy-like reactions have been described: rashes, itching, swelling, or trouble breathing. In rare cases, there have been reports of palpitations—those heart flutterings that make you wonder if too much coffee landed in your system.
Doctors and pharmacists know benproperine phosphate has some nervous system side effects. Its job is to tell the brain's cough center to relax. This interaction often brings along the potential for drowsiness and mild cognitive fuzziness. Pair that with alcohol or other sedatives, and the effects multiply dangerously. The elderly or anyone operating machinery or driving soon discover a new hazard.
Gastrointestinal issues are nearly as common as central nervous system complaints. Users sometimes wrestle with stomach pain, heartburn, nausea, or diarrhea. Not fun—especially for someone just trying to get a night's rest. In rare cases, liver and kidney issues have cropped up, but data remains thin. Pregnant and breastfeeding women face particular advice: best to avoid unless a doctor specifically recommends it, since evidence for safety doesn’t exist in that population.
The danger of combining this drug with others goes unnoticed in crowded pharmacies. Many over-the-counter cold pills blend multiple ingredients, each with its own baggage. Stacking drugs can amplify drowsiness and other side effects, an especially big deal for older adults. Overlooking this step risks accidents, medication errors, and side effect confusion. Healthcare providers routinely flag drug interactions and patient history, but in self-medication, those safety nets vanish.
Doctors recommend asking questions before grabbing a familiar cough remedy off the shelf. Pharmacists hold a wealth of information, but many of us hesitate to ask. Trustworthy information online, such as peer-reviewed clinical guidelines or national health websites, helps fill in gaps. Patients with existing health concerns—like chronic lung, heart, liver, or kidney problems—find that side effects land harder, linger longer, or become dangerous. For them, running a new medicine by a clinician remains the safest plan.
Benproperine phosphate does its job for cough relief. Still, no medicine works without a little risk, especially for those juggling other prescriptions. It pays off to stay alert—not just to potential cures, but to the baggage they bring along. Ask, read, and share your experiences with your doctor or pharmacist. That vigilance steers you away from trouble and toward better health outcomes.
Benproperine Phosphate has a single job in cold medicine: quiet the urge to cough. Since a cough sneaks up at the worst times—late nights, in packed subways, at work meetings—people want fast relief. But just because a pill promises to help, that doesn’t mean more is better. Sticking to the recommended dose isn’t about playing it safe; it’s about keeping your body from dealing with unwanted side effects like dizziness, upset stomach, or worse.
Most folks who pick up Benproperine Phosphate from the pharmacy find it in 25 mg tablets. Adults often swallow one tablet every eight to twelve hours. If you crunch the math, you’ll see guidelines usually hover around 50 mg or so in a full day. Kids under 12 need something different—lower, often adjusted by a pediatrician who actually knows their weight and age.
A lot of people think doubling up on pills will knock out their cough faster. In my own family, it’s a repeat conversation. My uncle once took a couple of extra tablets at night, expecting quicker relief. He ended up wide awake, with a racing pulse and a case of the shakes. That experience pushed him—and the rest of us—to read the leaflet every time before taking any medication.
Mixing Benproperine Phosphate with alcohol or sedative medicines can cause drowsiness. Some friends have tried to power through a day by stacking cold remedies, only to get behind the wheel and feel lightheaded. I learned from one friend’s mishap: he mixed more than one cough suppressant, lost focus, and had a fender bender. Now, he checks the active ingredients of every cough or cold remedy he buys, and encourages others to do the same.
It’s important to talk to your own doctor or a pharmacist, not just trust what you read online. People’s bodies react differently. If you’ve got kidney or liver problems or you’re pregnant, your prescription could change. Only a real medical professional can give the green light for you.
Not every cough deserves a suppressant. Sometimes, coughing keeps you alive. If you have a chest infection, your body uses a cough to clear junk out of your lungs. I remember someone close who had pneumonia and kept reaching for the cough tablets. The doctor actually said, “Let that cough do its job.” So, before you pop another tablet, think about why you’re coughing. It’s not about damping down every tickle.
If you forget a dose, you don’t need to play catch-up with extra tablets. Taking more than directed won’t make the cough go away faster. Instead, pour a glass of water, read the dosage instructions, and follow the next scheduled time. Report anything odd—like skin rashes or an unusually fast heartbeat—to whoever prescribed the drug.
For people living with chronic cough or underlying illnesses, regular check-ins with their doctor help prevent bigger problems. Sticking with recommended doses, reading packaging, and asking questions gives peace of mind—more than grabbing for an extra tablet ever could.
Parents hear a cough coming from the other room and many reach for something to help. Benproperine phosphate often finds its way into syrups labeled for relief. This medicine works by controlling the cough reflex and gets used in several countries as a prescription or even an over-the-counter solution. But the label rarely tells the whole story, especially for groups like kids and pregnant women.
Looking at safety, my gut always tells me not to gamble with a child’s health or the well-being of a baby on the way. Researchers have authorized benproperine phosphate for adult cough relief in places like Asia, but strong data on safety in children or expecting mothers just isn’t there. Regulatory agencies like the FDA or the European Medicines Agency have not cleared benproperine products for these groups. Digging through the available clinical studies, very few focus on kids, and virtually none on pregnant people. Without credible long-term studies, hope is not a plan.
Side effects show up even at regular doses. Drowsiness, nausea, stomach discomfort, and odd skin reactions happen often enough to spark concern. Kids metabolize drugs differently than adults, making them especially vulnerable to side effects or accidental overdoses. For growing babies in the womb, there’s an even bigger risk; medicines taken by the mother can pass through the placenta, and drugs not tested in pregnancy carry uncertainty for development.
Doctors and pharmacists often face desperate parents, especially in flu season. Many years in healthcare taught me that a parent’s worry is real. The urge to “do something” leads to grabbing whatever medicine promises relief. No cough syrup erases all risks. Without a green light from respected health agencies or robust clinical trials, no amount of anecdote overrides the lack of science. Memories haunt when medicine meant to help ends up causing harm.
For children, doctors recommend simple remedies before considering medicine. Sometimes a humidifier, a spoonful of honey for those older than one, or just plain rest encourages a quicker recovery. For pregnant women battling an irritating cough, plenty of fluids, saline gargles, and rest take top priority. Any medication use during pregnancy deserves guidance straight from a qualified healthcare provider.
Coughs sound worrying, but reaching for benproperine phosphate without good studies in children and pregnant women feels risky. Each family’s situation deserves thoughtful, informed decisions. A parent’s love shows up not just in the urge to treat, but by pausing and double-checking. Ask a doctor before using any unfamiliar cough medicine in these groups. Medical advice based on active research and trustworthy guidelines shapes safer choices, every time.
Doctors, policymakers, and pharmaceutical companies bear responsibility to fill these knowledge gaps. Clearer research into cough medicines for children and pregnant women will turn guessing into facts. As these answers appear, labels and law can protect families from harm. Until that happens, the safest answer comes from checking with a qualified professional — not a medicine shelf at home.
Benproperine phosphate usually shows up on pharmacy shelves as a cough suppressant, popular in places like South Korea and parts of Europe. A lot of people pick it up hoping for relief from nagging cough and irritation. But trust in any medicine grows from more than a quick check of the dose. People want to know if mixing it with other common drugs will give them trouble.
People expect a cough remedy to deliver quick results without too much complication. Benproperine works centrally on the brain’s cough center. It does not act as a narcotic or sedative, so it avoids many of the dangers tied to codeine. Still, nobody can ignore possible interactions, especially if someone already takes other medications every day.
Most studies and medical references say benproperine phosphate keeps a low profile when combined with other medicines. No dramatic, widespread interaction patterns stand out, which sets it apart from heavier prescription cough products. Patients taking multiple prescriptions at the same time, such as blood pressure medicines or diabetes pills, seem unlikely to run into infamous conflicts with this particular drug.
Yet research tells us to never take things at face value. Benproperine makes its way through the liver, passing over certain enzymes like CYP2D6 and CYP3A4. These enzymes have a long history of being involved in classic drug interactions. Imagine drinking grapefruit juice with cholesterol medicine—things can go wrong quickly if two drugs compete for these enzymes or block them. New research on benproperine points to a theoretical risk if someone takes strong enzyme inhibitors on top of it. Drugs like ketoconazole (used for fungal infections) or some HIV antivirals can block these liver enzymes and might increase the amount of benproperine hanging around in the body. High levels could lead to more side effects like drowsiness, dizziness, or unrest in sensitive patients.
Every health professional has seen patients juggling long medication lists. Even if published data on benproperine interactions stays quiet, caution always enters the picture for complex cases. For people with chronic illness, the risk comes not just from medicine-to-medicine interactions but from their own bodies' changing ability to process drugs. Liver problems, kidney issues, or advanced age slow down how any drug gets removed from the bloodstream, so things pile up faster than expected. Anyone on medications that mess with liver enzymes, or anyone with a history of unpredictable drug reactions, deserves a closer look before using benproperine phosphate.
Experience shows ordinary safety steps work better than fancy gadgets. Bring a full list of all your medicines when visiting a doctor or picking up a new prescription. Ask questions—don't let polite embarrassment get in the way of good information. Pharmacists have real-world insight about patterns they see in customers, so a quick chat can save hours of discomfort. Never skip warnings or fine print. Anyone who takes new drugs (for coughs or any other reason) should look out for new symptoms—if confusion, dizziness, or trouble breathing pops up soon after starting benproperine, get medical advice fast.
Cough suppression remains important for basic comfort, but the right way to use benproperine phosphate depends on patient knowledge. Checking for drug interactions beats relying on luck. A single conversation with a health professional can prevent days of side effects. Safe medicine use relies on honest communication, updated drug lists, and attention to signals from both body and science.
| Names | |
| Preferred IUPAC name | 2-[(2-benzylphenoxy)(propyl)amino]propan-1-ol dihydrogen phosphate |
| Other names |
Benpropine Benproperinum Benproperini phosphas BPP Cofsedan Coughset |
| Pronunciation | /benˈproʊpəriˌn faɪˈspeɪt/ |
| Identifiers | |
| CAS Number | 6290-17-1 |
| Beilstein Reference | 3980489 |
| ChEBI | CHEBI:3134 |
| ChEMBL | CHEMBL2105906 |
| ChemSpider | 13855208 |
| DrugBank | DB08982 |
| ECHA InfoCard | ECHA InfoCard: 100.054.349 |
| EC Number | EC 232-331-2 |
| Gmelin Reference | 81587 |
| KEGG | D07410 |
| MeSH | D014893 |
| PubChem CID | 124076 |
| RTECS number | TU8225000 |
| UNII | I809N4348J |
| UN number | UN3249 |
| CompTox Dashboard (EPA) | DJ1M372F3Y |
| Properties | |
| Chemical formula | C21H29NO5P |
| Molar mass | 545.52 g/mol |
| Appearance | White crystalline powder |
| Odor | Odorless |
| Density | 1.3 g/cm³ |
| Solubility in water | Slightly soluble |
| log P | 2.9 |
| Acidity (pKa) | 10.35 |
| Basicity (pKb) | 8.62 |
| Refractive index (nD) | 1.636 |
| Viscosity | Viscous liquid |
| Dipole moment | 2.99 D |
| Thermochemistry | |
| Std molar entropy (S⦵298) | 282.6 J·mol⁻¹·K⁻¹ |
| Pharmacology | |
| ATC code | R05DB14 |
| Hazards | |
| Main hazards | May cause respiratory depression, central nervous system effects, allergic reactions, and gastrointestinal disturbances. |
| GHS labelling | GHS02, GHS07, Signal Word: Warning |
| Pictograms | GHS07 |
| Signal word | Warning |
| Hazard statements | H302: Harmful if swallowed. |
| Precautionary statements | Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away. |
| NFPA 704 (fire diamond) | 1-1-0 Health:1 Flammability:1 Instability:0 |
| Flash point | 80°C |
| Lethal dose or concentration | LD50 (oral, rat): 330 mg/kg |
| LD50 (median dose) | LD50 (median dose) of Benproperine Phosphate: "237 mg/kg (oral, rat) |
| NIOSH | WZ9Q0G98KR |
| PEL (Permissible) | Not established |
| REL (Recommended) | 30 mg |
| Related compounds | |
| Related compounds |
Benproperine Benproperine citrate |
